| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.9 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.9 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |